Interference of benzo[a]pyrene diol epoxide‐deoxyguanosine adducts in a GC box with binding of the transcription factor Sp1

Previous studies indicated that DNA adducts formed by the carcinogenic diol epoxide 7r,8t‐dihydroxy‐9t,10t‐epoxy‐7,8,9,10‐tetrahydrobenzo[a]pyrene (BPDE) can increase the affinity of the transcription factor Sp1 for DNA sequences that are not normally specific binding sites. Whether adducts that form in the normal binding site, the GC box sequence, increase the affinity of Sp1 for the modified GC‐box was not determined. Starting with a 23‐nt sequence that contains two natural GC box sequences, site‐specifically modified oligonucleotides were prepared with a single (+)‐BPDE‐deoxyguanosine adduct at one of three positions: the center of each GC‐box or in between the two boxes. Four modified oligonucleotides were studied, two derived from cis addition of BPDE to the exocyclic amino group and two from trans addition. For three of these site‐specifically modified oligonucleotides, there was a diminution in Sp1 affinity, whereas Sp1 binding to the fourth modified oligonucleotide was abolished. Furthermore, random modification of the oligonucleotide to a level of about 1 BPDE adduct per fragment slightly decreased the affinity for Sp1, and no evidence was found for a subpopulation of molecules with high affinity. These findings suggest that BPDE modification of the GC box does not lead to an increased affinity for Sp1. This is consistent with a model in which a BPDE‐induced bend in the DNA mimics the conformation of the normal GC box:Sp1 complex, leading to high‐affinity binding of Sp1 to non‐GC box sites. © 1996 Wiley‐Liss, Inc.

[1]  M. Macleod.  A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression , 1996, Molecular carcinogenesis.

[2]  L. Romano,et al.  Benzo[a]pyrene-DNA adducts inhibit the DNA helicase activity of the bacteriophage T7 gene 4 protein. , 1996, Chemical research in toxicology.

[3]  C. Swenberg,et al.  Stereochemistry-dependent bending in oligonucleotide duplexes induced by site-specific covalent benzo[a]pyrene diol epoxide-guanine lesions. , 1995, Nucleic acids research.

[4]  K. Powell,et al.  Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. , 1995, Carcinogenesis.

[5]  S. Amin,et al.  Laser pulse-induced photochemical strand cleavage of site-specifically and covalently modified (+)-anti-benzo[a]pyrene diol epoxide-oligonucleotide adducts. , 1995, Chemical research in toxicology.

[6]  K. Kamiya,et al.  Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Geacintov,et al.  Synthesis and characterization of covalent adducts derived from the binding of benzo[a]pyrene diol expoxide to a -GGG- sequence in a deoxyoligonucleotide. , 1995, Carcinogenesis.

[8]  L. Hurley,et al.  Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. , 1994, Biochemistry.

[9]  D. K. Treiber,et al.  Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Geacintov,et al.  Site-specific benzo[a]pyrene diol epoxide-DNA adducts inhibit transcription elongation by bacteriophage T7 RNA polymerase. , 1994, Biochemistry.

[11]  D. Patel,et al.  Solution conformation of the (+)-cis-anti-[BP]dG adduct in a DNA duplex: intercalation of the covalently attached benzo[a]pyrenyl ring into the helix and displacement of the modified deoxyguanosine. , 1993, Biochemistry.

[12]  B. Nordén,et al.  Enhancement of binding rate of RecA protein to DNA by carcinogenic benzo[a]pyrene derivatives and selective change of adduct conformation. , 1993, Carcinogenesis.

[13]  N. Geacintov,et al.  Direct synthesis and identification of benzo[a]pyrene diol epoxide-deoxyguanosine binding sites in modified oligodeoxynucleotides. , 1992, Chemical research in toxicology.

[14]  D. Patel,et al.  Influence of benzo[a]pyrene diol epoxide chirality on solution conformations of DNA covalent adducts: the (-)-trans-anti-[BP]G.C adduct structure and comparison with the (+)-trans-anti-[BP]G.C enantiomer. , 1992, Biochemistry.

[15]  D. Patel,et al.  Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Harvey,et al.  Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity , 1992 .

[17]  A. Kennedy.  Is there a critical target gene for the first step in carcinogenesis? , 1991, Environmental health perspectives.

[18]  T. Krugh,et al.  Analysis of site-specific binding of (+/-)-anti-benzo[a]pyrene diol epoxide to restriction fragments of pBR322 DNA via photochemical mapping. , 1991, Chemical research in toxicology.

[19]  N. Geacintov,et al.  Preparation and isolation of adducts in high yield derived from the binding of two benzo[a]pyrene-7,8-dihydroxy-9,10-oxide stereoisomers to the oligonucleotide d(ATATGTATA). , 1990, Carcinogenesis.

[20]  L. Romano,et al.  Benzo[a]pyrene-DNA adducts inhibit translocation by the gene 4 protein of bacteriophage T7. , 1989, The Journal of biological chemistry.

[21]  F. Beland,et al.  DNA Adducts and Carcinogenesis , 1989 .

[22]  M. Macleod,et al.  Preferential modification of GC boxes by benzo[a]pyrene‐7,8‐diol‐9,10‐epoxide , 1989, Molecular carcinogenesis.

[23]  M. Macleod,et al.  A rapid, spectrophotometric assay for the integrity of diol epoxides. , 1988, Carcinogenesis.

[24]  J. H. Park,et al.  Analysis of signals controlling expression of the Chinese hamster ovary aprt gene , 1988, Molecular and cellular biology.

[25]  S. Nath,et al.  Effect of carcinogenic adducts on transcription by T7 RNA polymerase. , 1987, Nucleic acids research.

[26]  M. Hogan,et al.  High-resolution mapping of carcinogen binding sites on DNA. , 1986, Biochemistry.

[27]  M. Meuth,et al.  Nucleotide sequence of hamster adenine phosphoribosyl transferase (aprt) gene. , 1986, Nucleic acids research.

[28]  M. Hogan,et al.  Site-specific carcinogen binding to DNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Marshall,et al.  Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide , 1984, Nature.

[30]  R. Tjian,et al.  Multiple specific contacts between a mammalian transcription factor and its cognate promoters , 1984, Nature.

[31]  E C Miller,et al.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.

[32]  M. Takanami.  [56] RNA polymerase nascent product analysis , 1980 .

[33]  B. Strauss,et al.  Sites of inhibition of in vitro DNA synthesis in carcinogen- and UV-treated Φ174 DNA , 1979, Nature.

[34]  J. Barrett,et al.  Relationship between somatic mutation and neoplastic transformation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.